000 01509 a2200409 4500
005 20250516163947.0
264 0 _c20140514
008 201405s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00580-13
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNagaro, Kristin J
245 0 0 _aNontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cNov 2013
300 _a5266-70 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAdaptive Immunity
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aClindamycin
_xpharmacology
650 0 4 _aClostridioides difficile
_xdrug effects
650 0 4 _aCricetinae
650 0 4 _aCross Protection
650 0 4 _aEnterocolitis, Pseudomembranous
_ximmunology
650 0 4 _aImmunity, Heterologous
650 0 4 _aMale
650 0 4 _aMesocricetus
650 0 4 _aSpores, Bacterial
_xdrug effects
700 1 _aPhillips, S Tyler
700 1 _aCheknis, Adam K
700 1 _aSambol, Susan P
700 1 _aZukowski, Walter E
700 1 _aJohnson, Stuart
700 1 _aGerding, Dale N
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 57
_gno. 11
_gp. 5266-70
856 4 0 _uhttps://doi.org/10.1128/AAC.00580-13
_zAvailable from publisher's website
999 _c22999065
_d22999065